InsidersTradesSigma
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Browse the full record of transactions filed by O'Kane Sharon, Director. Director active across 1 company, notably LivaNova PLC. Cumulatively, 5 filings have been published. Activity tracked since 29 June 2021. The latest transaction was filed on 15 June 2024 (Levée d'options). Regulator: SEC (Form 4). The full history is accessible without signup.
5 of 5 declarations
Sharon O'Kane is a Board Member of LivaNova PLC. In this role, she contributes to the governance and strategic direction of the company. Her experience in the medical device sector allows her to provide valuable insights to board discussions.